Anti-C5 antibodies and methods of treating complement-related diseases
US11339210B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2019 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Feb 5, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an antibody against C5, and a method for preventing and treating complement-related diseases using the antibody, wherein the antibody against C5 is effectively usable in preventing and treating complement-related diseases by inhibiting complement activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.